Ana Paula Marte Chacra

ORCID: 0000-0002-2881-1820
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Lipoproteins and Cardiovascular Health
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Cancer, Lipids, and Metabolism
  • Public Health in Brazil
  • Healthcare Regulation
  • Cholesterol and Lipid Metabolism
  • Lipid metabolism and disorders
  • Hyperglycemia and glycemic control in critically ill and hospitalized patients
  • Cardiac Imaging and Diagnostics
  • Healthcare during COVID-19 Pandemic
  • Adipokines, Inflammation, and Metabolic Diseases
  • Nutrition, Genetics, and Disease
  • Aortic Thrombus and Embolism
  • Pancreatic and Hepatic Oncology Research
  • Blood Pressure and Hypertension Studies
  • Hormonal Regulation and Hypertension
  • Metabolism, Diabetes, and Cancer
  • Antioxidant Activity and Oxidative Stress
  • Coronary Interventions and Diagnostics
  • Youth, Drugs, and Violence
  • Diabetes Treatment and Management
  • Cardiovascular Effects of Exercise
  • Pancreatitis Pathology and Treatment
  • Liver Disease Diagnosis and Treatment
  • Agricultural and Food Sciences

Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
1999-2024

Universidade de São Paulo
2013-2024

Hospital São Paulo
2007-2023

Discovery Air (Canada)
2022

Hospital do Coração
2013-2021

Sociedade Brasileira de Cardiologia
2007

10.1590/s0066-782x2007000700002 article PT cc-by-nc Arquivos Brasileiros de Cardiologia 2007-04-01

Characterize homozygous familial hypercholesterolemia (HoFH) individuals from Iberoamerica. Approach and Results: In a cross-sectional retrospective evaluation 134 with HoFH phenotype, 71 adults (age 39.3±15.8 years, 38.0% males), 63 children 8.8±4.0 50.8% males) were studied. Genetic characterization was available in 129 (96%). The majority (91%) true homozygotes (true HoFH, n=79, 43.0% children, 46.8% or compound heterozygotes (compound heterozygous hypercholesterolemia, n=39, 51.3% 46.2%...

10.1161/atvbaha.120.313722 article EN PubMed 2020-10-01

Introdução A hipercolesterolemia familiar (HF) é uma causa genética comum de doença coronariana prematura, especialmente infarto do miocárdio, devido à exposição ao longo da vida a concentrações elevadas colesterol lipoproteína baixa densidade (LDL-c). Caracteriza-se por ser forma grave dislipidemia base genética, em que aproximadamente 85% dos homens e 50% das mulheres podem ter um evento coronariano antes completar os 65 anos idade, se não tratados adequadamente. HF considerada [...]

10.36660/abc.20210788 article PT cc-by-nc Arquivos Brasileiros de Cardiologia 2021-09-27

Sitosterolemia is a rare autosomal recessive disorder caused by homozygous or compound heterozygous variants in ABCG5/ABCG8. The disease characterized increased plasma plant sterols. Small case series suggest that patients with sitosterolemia have wide phenotypic heterogeneity great variability on either cholesterol levels development of atherosclerotic cardiovascular disease. present study aims to characterize the prevalence and clinical features participating familial hypercholesterolemia...

10.1161/circgen.121.003390 article EN Circulation Genomic and Precision Medicine 2022-05-12

We evaluated the effects of defatted amaranth (Amaranthus caudatus L.) snacks on plasma lipids in moderate hypercholesterolemic patients. Twenty-two subjects [30-65 years old), 11 males, with total cholesterol (TC) > 240 mg.dL-1, low-density (LDL-c) 160-190 mg.dL-1 and triglycerides (TG) < 400 mg.dL-1] were randomized a double blind clinical trial to receive an snack (50 g/day) or equivalent corn (placebo) for 2 months. There no differences between placebo TC LDL-c, TG respectively: -8.4...

10.1590/s0101-20612010000400026 article EN Food Science and Technology 2010-12-01

Abstract The objective of this study was to evaluate the kinetics both free and esterified forms cholesterol contained in a emulsion that binds LDL receptors (LDE) subjects with heterozygous familial hypercholesterolemia (FH), same under effects high‐dose simvastatin treatment, as compared control normolipidemic group (NL). Twentyone FH patients (44.0±13.0 yr, 12 females, levels 6.93±1.60 mmol/L) 22 (44.0±15.0, 10 3.15±0.62 were injected intravenously 14 C‐cholesteryl ester 3 H‐cholesterol....

10.1007/s11745-005-1437-6 article EN Lipids 2005-07-01

During hypoxia, active substances released by the endothelium play a key role in cardiovascular and respiratory responses elicited to optimize oxygen delivery. As hypercholesterolemia is major cause of endothelial dysfunction, it may interfere with these responses.We studied ventilatory acute systemic hypoxia 14 patients (HC) 13 control (CO) subjects. Oxygen saturation decreased similarly both groups. Diastolic blood pressure increased only HC group (P=0.0002) and, despite systolic increases...

10.1161/01.atv.0000089471.61037.21 article EN Arteriosclerosis Thrombosis and Vascular Biology 2003-08-05

The platelet indices Mean Platelet Volume (MPV), Distribution Width (PDW) and Plate-letcrit (PCT) provided by automated hematology analysis are rarely used in clinical practice. Platelets play a central role the pathogenesis of acute coronary syndromes (ACS) high MPV has been associated to more reactive platelets regarded as an independent risk factor for myocardial infarction. In this study, were evaluated 39 patients with ACS presenting two altered biochemical parameters, C protein (CRP)...

10.4236/jbm.2015.311009 article EN Journal of Biosciences and Medicines 2015-01-01

Carta de Apresentação A síndrome da quilomicronemia familiar (SQF) é uma forma grave dislipidemia e compreende um conjunto múltiplos sinais sintomas causados pela deficiência enzima lipoproteína lipase (LPL) ou seus cofatores, comprometendo o metabolismo triglicérides. Apresenta modo herança autossômico recessivo acomete cerca 1 a 2 pessoas por milhão indivíduos, mas pode ser mais frequente quando existe consanguinidade. Existe grande desconhecimento sobre essa condição e, esse motivo, [...]

10.36660/abc.20230203 article PT cc-by-nc Arquivos Brasileiros de Cardiologia 2023-04-01

Metabolic syndrome (MetS) refers to states of insulin resistance that predispose development cardiovascular disease and type 2 diabetes (T2DM). The aim was investigate whether plasma lipids lipid metabolism differ in MetS patients compared those with T2DM poor glycemic control (glycated hemoglobin > 7.0). Eighteen T2DM, 18 14 controls, paired for age (40-70 years) body mass index (BMI), were studied. Plasma the kinetics a triacylglycerol-rich emulsion labeled [(3)H]-triolein ([(3)H]-TAG)...

10.1007/s11745-014-3899-2 article EN Lipids 2014-04-09
Coming Soon ...